Early Recurrences of Atrial Arrhythmias and Their Impact on Late Recurrence After Pulmonary Vein Isolation With Pulsed Field Ablation of Paroxysmal Atrial Fibrillation
Launched by UNIVERSITY OF SPLIT, SCHOOL OF MEDICINE · Apr 7, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how early episodes of irregular heartbeats, called atrial fibrillation (AF), after a specific heart procedure known as pulsed field ablation (PFA) can affect the chances of having more episodes later on. The trial is taking place at the University Hospital of Split and involves patients who have experienced symptomatic paroxysmal atrial fibrillation, which means their AF comes and goes but is bothersome. Participants will have a small device called an implantable loop recorder placed in their body after the PFA to monitor their heart rhythm. The study will follow patients over a year to see how often they experience these irregular heartbeats and if early episodes lead to more problems later.
To be eligible for the trial, patients must be over 18 years old and have had a prior unsuccessful attempt to manage their AF with medication. However, those with certain health issues, such as a history of heart surgery, other medical conditions causing AF, or those who are pregnant or breastfeeding, will not be included. Participants can expect regular follow-up visits at 1, 3, 6, and 12 months after their treatment, where their heart rhythm will be checked, and any symptoms will be discussed. This study aims to improve the understanding of AF management and help doctors provide better care for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>18
- • Index PFA procedure after one failed or intolerant group I or III of the antiarrhythmic drug in patients with symptomatic paroxysmal AF (AF with self-terminating episodes lasting no longer than 7 continuous days)
- • Willing and able to provide informed consent.
- Exclusion Criteria:
- • Any known contraindication to AF ablation or anticoagulation.
- • History of previous left atrial ablation or surgical treatment.
- • Secondary AF due to reversible or non-cardiac cause such as thyroid disease and electrolyte imbalance.
- • Asymptomatic AF patients, persistent AF, permanent AF patients.
- • History of clotting or bleeding disease or cryoglobulinemia.
- • Pregnant or lactating.
- • Other conditions that may make the patient a poor candidate for procedure such as mental illness, terminal illness, vulnerable patient population.
About University Of Split, School Of Medicine
The University of Split, School of Medicine is a leading academic institution dedicated to advancing medical education, research, and clinical practice. Committed to fostering innovation and improving patient care, the School conducts rigorous clinical trials that explore cutting-edge therapies and interventions. With a focus on collaboration and multidisciplinary approaches, the institution aims to translate research findings into practical applications, enhancing healthcare outcomes both locally and globally. Through its robust infrastructure and expertise, the University of Split School of Medicine strives to contribute significantly to the medical field and the well-being of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Split, Splitsko Dalmatinska, Croatia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials